# NEXT Life Sciences

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/next-life-sciences

- Industry: Medical Devices & Equipment
- Headquarters: San Luis Obispo, US
- Website: www.nextlifesciences.org/
- Total disclosed funding: $2.5M
- Latest round: Seed (Jan 16, 2024)
- Investors on record: 7

## About

Based in California, US, NEXT Life Sciences, Inc., a.k.a. NEXT Life Sciences is developing a procedure to bring a non-hormonal, long-lasting, and reversible male contraception solution. In January 2025, NEXT Life Sciences, Inc. raised USD 200,000 in grant funding from returning investor Male Contraceptive Initiative. As of June 2023, L.R. Fox is the CEO of the company.

The company provides Plan A™, which is a reversible birth control for men. The Plan A™ treatment is comparable to a no-scalpel vasectomy, with the exception that the hydrogel serves as a flexible filter to stop the passage of sperm, preventing pregnancy rather than irreversibly severing the vas deferens.

The company plans to use its proceeds from Jan 2025 funding to continue to develop its product, called Plan A.

## Funding rounds

- Seed, Jan 16, 2024, $2.5M — StartUp Health, Particular Ventures, The Family, Transform VC, Unpopular Ventures, PIF Capital Management, JoyFund

## Investors

- StartUp Health (https://capitalatlas.ai/funds/startup-health) — Seed
- Particular Ventures (https://capitalatlas.ai/funds/particular-ventures) — Seed
- The Family (https://capitalatlas.ai/funds/the-family) — Seed
- Transform VC (https://capitalatlas.ai/funds/transform-vc) — Seed
- Unpopular Ventures (https://capitalatlas.ai/funds/unpopular-ventures) — Seed
- PIF Capital Management (https://capitalatlas.ai/funds/pif-capital-management) — Seed
- JoyFund (https://capitalatlas.ai/funds/joyfund) — Seed